OTC Homeopathic Claims Go Under FTC Microscope, Potential For Regulatory Shift Magnifies
This article was originally published in The Pink Sheet Daily
Executive Summary
FTC says the homeopathic market “shifted from one based primarily on formulations prescribed for an individual user to mass-market formulations widely advertised and sold nationwide in major retail stores.” The workshop could signal FTC interest in asking for clinical trials to support for OTC homeopathic claims.